NATCO , reversal breakNATCO Pharma, after a downtrend, moving in a higher high pattern. Hope fully a break out from this trend line. Lets see how it may behave from here. next levels have been provided.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
105.25 INR
18.85 B INR
44.30 B INR
86.73 M
About NATCO PHARMA LTD.
Sector
Industry
CEO
Rajeev Nannapaneni
Website
Headquarters
Hyderabad
Founded
1981
ISIN
INE987B01026
FIGI
BBG000F4LTG0
NATCO Pharma Ltd. engages in the business of pharmaceuticals with research, manufacturing and marketing of finished dosage formulations and active pharmaceutical ingredients. It operates through the following segments: Domestic Formulations, International Formulations, and Active Pharmaceutical Ingredients. The Domestic Formulations segment operates in the divisions of oncology, pharma specialties and CnD. The International Formulations segment exports its FDF products from India to several international geographies either through its local partners or directly through its subsidiaries such as in Canada and Brazil. The Active Pharmaceutical Ingredients segment is strategically important as it develops APIs for the captive consumption of many of NATCO's critical FDF products in addition to supplying to direct customers. The company was founded by Venkaiah Chowdary Nannapaneni in 1981 and is headquartered in Hyderabad, India.
Related stocks
NATCOPHARM Swing TradeNATCOPHARM Swing Trade
Buy Price - 1318
T1 - 1730 (Time Frame - 4 to 6 Months)
T2 - 2600 (Time Frame - 6 to 12 months)
Natco Pharma Breakout Stock Natco Pharma (NATCOPHARM) is showing a strong breakout on the charts, supported by positive price action and increased buying interest. The stock has moved above key resistance levels, indicating bullish momentum. With improving volumes and a solid technical setup, NATCOPHARM looks well-positioned f
Review and plan for 29th May 2025 Nifty future and banknifty future analysis and intraday plan.
Quarterly results.
.
This video is for information/education purpose only. you are 100% responsible for any actions you take by reading/viewing this post.
please consult your financial advisor before taking any action.
----Vinay
SAR+ GANN9+ FIBO Retracement TAParabolic Stop and Reverse (SAR, PSAR) was originally developed by J. Welles Wilder. It derives its name from the fact that when charted, the pattern formed by the points resembles a parabola. A buy label is observed on the chart . The dots show the support points for the rising trend.
The price w
POV : NATCOPHARM : Head & Shoulder POV : NATCOPHARM : Head & Shoulder
Expected Entry and pattern Target mentioned on Chart
For educational purposes only. This is not financial advice. Please consult a professional before making financial decisions.
#NiVYAMi
Natco Pharma 1 dRising Channel pattern.
Stock moving in upward direction . if it continues the same direction may go upwards.
RSI divergence . Price moving up and RSI in nearly on same level .
View . Neutral to slight positive
Natco Pharma - Bullish - Long termStock is looking bullish above 1400 levels
Long term investors can accumulate in every dips and maintain a stop loss of 1175
Short term traders wait for retracements below 1400 level to accumulate and wait for the target of 1650
Hold for long term targets of 1700, 1850, 1900, 2000 levels
Short
UPSIDE potential in Natco pharmabreak of inverse head and shoulder pattern can be witnessed in natco pharma AND overall sentiment in pharma sector are also bullish . IT may try to break its all time high level in upcoming few month as per my expectation dec end might be the one looking for.
Can be good trade for swing. Time arou
Chart say everything with Elliott wave counts and Chart PatternsChart say everything with Elliott wave counts and Chart Patterns
Looks like Inverted Head n Shoulder chart pattern, yet to Break above Neckline.
Scenario also aligns with Impulse wave counts.
Elliott Wave Counts
Inverted Head n Shoulder Chart Pattern Yet to confirm Breakout
I am not Sebi re
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of NATCOPHARM is 961.80 INR — it has decreased by −3.66% in the past 24 hours. Watch NATCO PHARMA LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange NATCO PHARMA LTD. stocks are traded under the ticker NATCOPHARM.
NATCOPHARM stock has fallen by −1.48% compared to the previous week, the month change is a 8.08% rise, over the last year NATCO PHARMA LTD. has showed a −19.58% decrease.
We've gathered analysts' opinions on NATCO PHARMA LTD. future price: according to them, NATCOPHARM price has a max estimate of 1,460.00 INR and a min estimate of 772.00 INR. Watch NATCOPHARM chart and read a more detailed NATCO PHARMA LTD. stock forecast: see what analysts think of NATCO PHARMA LTD. and suggest that you do with its stocks.
NATCOPHARM reached its all-time high on Sep 12, 2024 with the price of 1,639.00 INR, and its all-time low was 1.70 INR and was reached on Jul 10, 2001. View more price dynamics on NATCOPHARM chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
NATCOPHARM stock is 3.98% volatile and has beta coefficient of 1.16. Track NATCO PHARMA LTD. stock price on the chart and check out the list of the most volatile stocks — is NATCO PHARMA LTD. there?
Today NATCO PHARMA LTD. has the market capitalization of 172.26 B, it has increased by 7.04% over the last week.
Yes, you can track NATCO PHARMA LTD. financials in yearly and quarterly reports right on TradingView.
NATCO PHARMA LTD. is going to release the next earnings report on Aug 7, 2025. Keep track of upcoming events with our Earnings Calendar.
NATCOPHARM earnings for the last quarter are 22.85 INR per share, whereas the estimation was 10.80 INR resulting in a 111.57% surprise. The estimated earnings for the next quarter are 36.90 INR per share. See more details about NATCO PHARMA LTD. earnings.
NATCO PHARMA LTD. revenue for the last quarter amounts to 12.21 B INR, despite the estimated figure of 12.91 B INR. In the next quarter, revenue is expected to reach 14.99 B INR.
NATCOPHARM net income for the last quarter is 4.07 B INR, while the quarter before that showed 1.33 B INR of net income which accounts for 205.71% change. Track more NATCO PHARMA LTD. financial stats to get the full picture.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NATCO PHARMA LTD. EBITDA is 21.96 B INR, and current EBITDA margin is 49.58%. See more stats in NATCO PHARMA LTD. financial statements.
Like other stocks, NATCOPHARM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NATCO PHARMA LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NATCO PHARMA LTD. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NATCO PHARMA LTD. stock shows the neutral signal. See more of NATCO PHARMA LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.